Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial
Jesper Høiberg Erichsen, Lars M Holm, Mads Forslund Jacobsen, Julie L Forman, Line Kessel, Jesper Høiberg Erichsen, Lars M Holm, Mads Forslund Jacobsen, Julie L Forman, Line Kessel
Abstract
Importance: The choice of anti-inflammatory prophylaxis parallel to cataract surgery is important for patient safety and successful outcome of surgery, but which regimen to choose is contested.
Objectives: To determine whether a combination of prednisolone and nonsteroidal anti-inflammatory drug (NSAID) eye drops was superior in preventing increased central macular thickness (central subfield thickness [CST]) after uncomplicated cataract surgery compared with NSAID monotherapy and sub-Tenon capsule depot (dropless surgery), and to test whether preoperative initiation of eye drop treatment was superior to initiation on the day of surgery.
Design, setting, and participants: This investigator-driven, single-center, randomized clinical trial with masked statistical analyses enrolled patients at the Department of Ophthalmology, Rigshospitalet Glostrup, Glostrup, Denmark, from February 1, 2018, to August 15, 2019. Follow-up was completed December 18, 2019. Participants included low-risk patients undergoing phacoemulsification for age-related cataract by an experienced surgeon (1 eye per participant). Data were analyzed from February 17 to June 15, 2020.
Interventions: Participants scheduled for cataract removal were randomized to 1 of 5 anti-inflammatory prophylactic regimens: eye drops with a combination of prednisolone, 1%, and ketorolac tromethamine, 0.5%, with or without preoperative initiation (preoperative prednisolone plus NSAID [control] and postoperative prednisolone plus NSAID groups), ketorolac monotherapy with or without preoperative initiation (preoperative and postoperative NSAID groups), or sub-Tenon depot of dexamethasone phosphate (sub-Tenon group). Eye drops were administered 3 times per day until 3 weeks postoperatively.
Main outcomes and measures: CST 3 months postoperatively.
Results: A total of 470 participants (mean [SD] age, 72.2 [7.0] years; 290 women [61.7%]) with 94 participants in each group were included in the analysis. Three months after surgery, the mean CST was 250.7 (95% CI, 247.6-253.7) μm in the preoperative prednisolone plus NSAID group, 250.7 (95% CI, 247.8-253.7) μm in the postoperative prednisolone plus NSAID group, 251.3 (95% CI, 248.2-254.4) μm in the preoperative NSAID group, 249.2 (95% CI, 246.2-252.3) μm in the postoperative NSAID group, and 255.2 (95% CI, 252.0-258.3) μm in the sub-Tenon group. There were no significant differences in CST or visual acuity compared with control and no differences between preoperative and postoperative groups, but 47 of 83 participants (56.6%) in the sub-Tenon group needed additional anti-inflammatory treatment.
Conclusions and relevance: No differences in CST or visual acuity were detected between the combination of prednisolone and NSAID eye drops vs NSAID monotherapy or sub-Tenon dexamethasone depot, although more than one-half of patients in the sub-Tenon arm received additional anti-inflammatory treatment. Initiating prophylaxis 3 days preoperatively was not superior to initiation on the day of surgery. Monotherapy with NSAIDs may be preferred in uncomplicated cataract surgery.
Trial registration: ClinicalTrials.gov Identifier: NCT03383328.
Conflict of interest statement
Conflict of Interest Disclosures: None reported.
Figures
References
- Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC; United Kingdom Pseudophakic Macular Edema Study Group . Risk factors and incidence of macular edema after cataract surgery: a database study of 81 984 eyes. Ophthalmology. 2016;123(2):316-323. doi:10.1016/j.ophtha.2015.10.001
- Shorstein NH, Liu L, Waxman MD, Herrinton LJ. Comparative effectiveness of three prophylactic strategies to prevent clinical macular edema after phacoemulsification surgery. Ophthalmology. 2015;122(12):2450-2456. doi:10.1016/j.ophtha.2015.08.024
- Kessel L, Tendal B, Jørgensen KJ, et al. . Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology. 2014;121(10):1915-1924. doi:10.1016/j.ophtha.2014.04.035
- Guo S, Patel S, Baumrind B, et al. . Management of pseudophakic cystoid macular edema. Surv Ophthalmol. 2015;60(2):123-137. doi:10.1016/j.survophthal.2014.08.005
- Lim BX, Lim CHL, Lim DK, Evans JR, Bunce C, Wormald R. Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery. Cochrane Database Syst Rev. 2016;11(11):CD006683. doi:10.1002/14651858.CD006683.pub3
- Juthani VV, Clearfield E, Chuck RS. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery. Cochrane Database Syst Rev. 2017;7:CD010516. doi:10.1002/14651858.CD010516.pub2
- Colin J. The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs. 2007;67(9):1291-1308. doi:10.2165/00003495-200767090-00004
- Wielders LHP, Lambermont VA, Schouten JSAG, et al. . Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. Am J Ophthalmol. 2015;160(5):968-981.e33. doi:10.1016/j.ajo.2015.07.032
- Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg. 2006;32(9):1474-1482. doi:10.1016/j.jcrs.2006.04.009
- Kim SJ, Schoenberger SD, Thorne JE, Ehlers JP, Yeh S, Bakri SJ. Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122(11):2159-2168. doi:10.1016/j.ophtha.2015.05.014
- Yavas GF, Oztürk F, Küsbeci T. Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. J Cataract Refract Surg. 2007;33(5):804-807. doi:10.1016/j.jcrs.2007.01.033
- Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol. 1990;74(8):477-480. doi:10.1136/bjo.74.8.477
- Dieleman M, Wubbels RJ, van Kooten-Noordzij M, de Waard PWT. Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery. J Cataract Refract Surg. 2011;37(9):1589-1597. doi:10.1016/j.jcrs.2011.03.049
- Athanasiadis Y, Tsatsos M, Sharma A, Hossain P. Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease. J Ocul Pharmacol Ther. 2013;29(6):516-522. doi:10.1089/jop.2012.0208
- World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1001/jama.2013.281053
- Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. doi:10.1016/j.jbi.2008.08.010
- Harris PA, Taylor R, Minor BL, et al. ; REDCap Consortium . The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi:10.1016/j.jbi.2019.103208
- Early Treatment Diabetic Retinopathy Study Design and Baseline Patient Characteristics . Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS report number 7. Ophthalmology. 1991;98(5)(suppl):741-756. doi:10.1016/S0161-6420(13)38009-9
- Wielders LHP, Schouten JSAG, Winkens B, et al. ; ESCRS PREMED Study Group . European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg. 2018;44(4):429-439. doi:10.1016/j.jcrs.2018.01.029
- Age-Related Eye Disease Study Research Group . The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS report No. 4. Am J Ophthalmol. 2001;131(2):167-175. doi:10.1016/S0002-9394(00)00732-7
- R Core Team . R: a language and environment for statistical computing. R Foundation for Statistical Computing; 2019. Accessed July 3, 2021.
- Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. John Wiley & Sons Inc; 2011. doi:10.1002/9781119513469
- Benjamini Y, Hochberg Y.. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289-300. doi:10.1111/j.2517-6161.1995.tb02031.x
- Zafar S, Wang P, Schein OD, Srikumaran D, Makary M, Woreta FA. Prescribing patterns and costs associated with postoperative eye drop use in Medicare beneficiaries undergoing cataract surgery. Ophthalmology. 2020;127(5):573-581. doi:10.1016/j.ophtha.2019.11.005
- Ylinen P, Holmström E, Laine I, Lindholm J-M, Tuuminen R. Anti-inflammatory medication following cataract surgery: a randomized trial between preservative-free dexamethasone, diclofenac and their combination. Acta Ophthalmol. 2018;96(5):486-493. doi:10.1111/aos.13670
- Erichsen JH, Forman JL, Holm LM, Kessel L. Effect of anti-inflammatory regimen on early postoperative inflammation after cataract surgery. J Cataract Refract Surg. 2021;47(3):323-330. doi:10.1097/j.jcrs.0000000000000455
- Lindholm JM, Taipale C, Ylinen P, Tuuminen R. Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery. Acta Ophthalmol. 2020;98(1):36-42. doi:10.1111/aos.14175
- Wielders LHP, Schouten JSAG, Winkens B, et al. ; ESCRS PREMED study group . Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2. J Cataract Refract Surg. 2018;44(7):836-847. doi:10.1016/j.jcrs.2018.05.015
- Laursen SB, Erichsen JH, Holm LM, Kessel L. Prevention of macular edema in patients with diabetes after cataract surgery. J Cataract Refract Surg. 2019;45(6):854-869. doi:10.1016/j.jcrs.2019.04.025
- Shorstein NH, Myers WG. Drop-free approaches for cataract surgery. Curr Opin Ophthalmol. 2020;31(1):67-73. doi:10.1097/ICU.0000000000000625
- Donnenfeld ED, Holland EJ, Solomon KD. Safety and efficacy of nepafenac punctal plug delivery system in controlling postoperative ocular pain and inflammation after cataract surgery. J Cataract Refract Surg. 2021;47(2):158-164. doi:10.1097/j.jcrs.0000000000000414
Source: PubMed